• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Boehringer Ingelheim, GWT and TU Dresden sign diabetes research collaboration

Boehringer Ingelheim, GWT and TU Dresden sign diabetes research collaboration

February 7, 2012
CenterWatch Staff

Boehringer Ingelheim, GWT and the Department of Medicine of the TU Dresden have signed a research collaboration agreement to develop new insights into the causes of diabetes and the link between excessive blood glucose, the hallmark of diabetes, and the serious complications of the disease that can affect many organ functions.

As partners, Boehringer Ingelheim, GWT and the TU Dresden will work together to enhance the knowledge of the disease to ultimately enable the discovery and development of innovative therapies that will treat these diseases more effectively. The five-year industry-academia collaboration strengthens Boehringer Ingelheim’s efforts to translate basic scientific findings into more effective treatments of human diseases.

The partners have initially defined six research projects bridging pre-clinical findings in the laboratory or from investigational treatments with the corresponding clinical situation with patients. The projects range from the exploration of causes for the destruction of insulin-producing beta cells to the cells and molecules triggering diabetic complications in organs such as the eye (diabetic retinopathy), which can lead to blindness, kidney (nephropathy), nerves (neuropathy) or skin (ulcerations).

Results from these studies may help to design new medicines for clinical testing, or to better understand how drug candidates can be tested with biomarkers and ultimately used in an optimal way for those patients most likely to show clinical benefit.

The GWT-TUD is a company of the TUDAG-Group, the Technische Universität Dresden. It is a service provider for knowledge and technology transfers and creates solutions for concrete projects and questions raised in R&D for clients in the industry.

The Dresden Diabetes Research Center in Germany, led by Professor Stefan Bornstein, treats 30,000 patients annually. In cooperation with the Paul-Langerhans-Institut at the Dresden University hospital, new therapies are explored.

 

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing